First AD

Second AD

Environmental Interventions Are Effective in Both Cost and Outcomes

Wanda Phipatanakul, MD, MS: The Need for Pollution-Based Health Research

Claus Bachert, MD, PhD: Why Monoclonal Antibodies Work for Asthma

Mepolizumab: A Proven Alternative to Omalizumab

US, UK Studies Examine Whether Increasing Glucocorticoid Reduces Asthma Exacerbations

Unnatural Allergen Eases Grass Pollen Allergy

Clearing the Air on Effects of Smoking in Asthma

Monitoring FeNO Reduces Asthma Hospitalizations, Saves Costs

Marc Massanari, PharmD: The History of Inflammation in Asthma

Allergic Multimorbidity May Cause More Severe Allergic Disease

Eosinophilic Disorder Therapy AK002 Shows Success in Phase 1

Jonathan Spergel, MD, PhD: The Takeaways from AAAAI/WAO 18

Jonathan Spergel, MD, PhD: Environmental Controls and Cost-Effectiveness in Allergy

Jonathan Spergel, MD, PhD: Interdisciplinary Care and Personalized Medicine for Allergy

Post Conference Perspectives

Allergy

Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.

Asthma

Pulmonology

Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.

AAAI/WAO 2018 Perspectives